Symptomatic treatment of migraine in children: A systematic review of medication trials

Pediatrics

Volumn 116, Issue 2, 2005, Pages

  Damen, Léonie ^a   Bruijn, Jacques K J ^a,b   Verhagen, Arianne P ^a   Berger, Marjolein Y ^a   Passchier, Jan ^a   Koes, Bart W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Vlietland Hospital   (Netherlands)

Author keywords

Children; Clinical trials; Medication; Migraine; Symptomatic treatment; Systematic review

Indexed keywords

ANALGESIC AGENT; DIHYDROERGOTAMINE; IBUPROFEN; KETOROLAC; NIMESULIDE; PARACETAMOL; PLACEBO; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; SEROTONIN AGONIST; SULFONAMIDE;

ABDOMINAL DISCOMFORT; BODY TEMPERATURE DISORDER; BURNING SENSATION; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG TOLERANCE; FEMALE; HEADACHE; HUMAN; JOINT STIFFNESS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PARESTHESIA; PHOTOPHOBIA; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYMPTOMATOLOGY; TASTE DISORDER; VOMITING; ADOLESCENT; META ANALYSIS; PRESCHOOL CHILD;

ACETAMINOPHEN; ADOLESCENT; ANALGESICS, NON-NARCOTIC; CHILD; CHILD, PRESCHOOL; CONTROLLED CLINICAL TRIALS; DIHYDROERGOTAMINE; FEMALE; HUMANS; IBUPROFEN; KETOROLAC; MALE; MIGRAINE DISORDERS; PROCHLORPERAZINE; RANDOMIZED CONTROLLED TRIALS; SEROTONIN AGONISTS; SULFONAMIDES; SUMATRIPTAN;

EID: 30444459592     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-2742     Document Type: Review

References (22)

1. Annequine D, Tourniaire B, Massiou H. Migraine and headache in children and adolescence. Pediatr Clin North Am. 2000;37:617-631
2. Guidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998;18:455-462
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96
4. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24(suppl 1):1-152
5. Major PW, Grubisa HIS, Thie NMR. Triptans for treatment of acute pediatric migraine: a systematic literature review. Pediatr Neurol. 2003;29:425-429
6. Robinson KA, Dickerson K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol. 2002;31:150-153
7. Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA. 1962;179:717-718
8. Verhagen AP, de Vet HCW, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomised clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235-1241
9. van Tulder M, Furlan A, Bombardier C, Bouter L; Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine. 2003;28:1290-1299
10. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43:256-262
11. Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506-510
12. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48:103-107
13. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989-997
14. Lewis DW, Kellstein D, Dahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780-786
15. Soriani S, Battistella PA, Naccarella C, Tozzi E, Fiumana E, Fanaro S. Nimesulide and acetaminophen for the treatment of juvenile migraine: a study for comparison of efficacy, safety, and tolerability. Headache Q. 2001;12:233-236
16. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology. 2004;62:883-887
17. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:1507-1510
18. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 1997;48:1100-1103
19. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK; Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002;42:49-55
20. Hämäläinen ML, Hoppu K, Santavuori PR. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol. 1997;16:114-117
21. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215-2224
22. Culter NR, Hussey EK, Sramek JJ, et al. Pharmacokinetics of oral sumatriptan in migraine patients during an attack and while pain free. Biol Psychiatry. 1992;31:180A